Blood marker may outshine scans for testicular cancer detection
NCT ID NCT07453082
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study is testing whether a blood marker called miRNA371 can detect active germ cell tumors more accurately than standard imaging. Researchers will collect blood samples and perform scans on 100 adults newly diagnosed with germ cell tumors. The goal is to see if this marker can find hidden malignant cells or predict disease progression earlier.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood test to detect active germ cell tumors earlier or more accurately than current imaging.
- What could go wrong
- This is an early observational study, not a treatment trial. The marker may not prove reliable enough for routine use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERM CELL TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione del Piemonte per l'Oncologia
RECRUITINGCandiolo, Turin, 10060, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Glowing dye could reveal hidden cancer spread in testicular tumors
- High-Dose chemo with stem cell transplant tested against standard therapy for tough germ cell cancers
- Could a dementia drug shield kids' brains from radiation damage?
- Dietary change explored as cancer support strategy
- Hypnosis may ease chemo anxiety in teens and young adults
- Could a simple pill keep relapsed testicular cancer at bay?